Glipizide Tablet, Film Coated, Extended Release
Product Images NDC 51655-337

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Glipizide (NDC 51655-337). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Northwind Health Company, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Label (51655 337 26 Master Bottle Label Approval Rev A 05 20)

Glipizide Extended-Release Tablets, 5 mg, film-coated oral tablets. The label indicates a package size of 90 tablets and provides storage instructions to keep at controlled room temperature and protect from moisture and humidity. The product is labeled for prescription use only and manufactured by Northwind Pharmaceuticals.*

FDA Label Image

Structural Formula (Structural Formula)

Chemical structure of Glipizide, the active ingredient in the product. The diagram depicts the molecular arrangement including rings, functional groups, and bonds characteristic of Glipizide.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.